Shi 2005.
Methods | Six‐week, (likely) randomised study. |
Participants | In‐patients with depression according to CCMD‐III criteria. |
Interventions | Citalopram: 30 participants. Maprotiline: 30 participants. Citalopram dose range: 20 mg/day. Maprotiline dose range: 100‐200 mg/day. |
Outcomes | Change in Hamilton Depression Rating Scale (HDRS) score from baseline to endpoint, number of patients who responded to treatment. |
Notes | Waiting for translation from Chinese to English (only abstract available in English). |